OmniSpirant Therapeutics
PrivateLast Round
Seed
Jan 14, 2025
Total Funding Raised
$13.81M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
OmniSpirant Therapeutics operates in Healthcare & Life Sciences and is based in Ireland. Its latest recorded funding round was a Grant round in February 2023.
OmniSpirant Therapeutics is a biotechnology company developing a first-in-class regenerative gene therapy platform, 'OmniSomes', for RNA-based treatments targeting respiratory diseases and cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OmniSpirant Therapeutics Comparables
Compare OmniSpirant Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EVerMed, Inc. | 82% | |
| SpliSense | 81% | |
| Xsome Biotech | 80% |
For institutional investors. Book with your work email.
OmniSpirant Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 14, 2025 | ||||
| Grant | Feb 14, 2023 | ||||
| Grant | Jun 1, 2022 | ||||
| Grant | Feb 1, 2019 |
For institutional investors. Book with your work email.
OmniSpirant Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Commission | Grant |
| Emily's Entourage | Grant |
| Horizon Europe | Grant |
| Cystic Fibrosis Trust | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 32% MoM.
- Jun 1, 2026
Grew 30% QoQ from 10 to 13 employees.
For institutional investors. Book with your work email.
OmniSpirant Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about OmniSpirant Therapeutics's valuation, stock price, and market status.
Is OmniSpirant Therapeutics a public or private company?
OmniSpirant Therapeutics is a private company.
What is the current stock price of OmniSpirant Therapeutics?
OmniSpirant Therapeutics is a private company, so its shares have no public market price. Caplight tracks OmniSpirant Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is OmniSpirant Therapeutics worth (valuation)?
Valuation information for OmniSpirant Therapeutics is not publicly available.
Can I buy OmniSpirant Therapeutics stock?
OmniSpirant Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was OmniSpirant Therapeutics's last funding round?
OmniSpirant Therapeutics's most recent funding round was Seed on January 14, 2025.
Who are the main investors in OmniSpirant Therapeutics?
Key investors in OmniSpirant Therapeutics include European Commission, Emily's Entourage, Horizon Europe.
Will OmniSpirant Therapeutics IPO soon?
No public IPO plans have been announced for OmniSpirant Therapeutics.
How can I track OmniSpirant Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in OmniSpirant Therapeutics's shares on secondary markets.